Fierce Pharma Week Europe 2027
Basel is one of Europe’s most concentrated life sciences hubs. This is precisely where MCH Group’s strategic partnerships come into play: together with Questex and its life sciences brand Fierce Pharma, a new international platform for the pharmaceutical industry will launch in Basel in 2027.
Questex is an international events and media company with a strong focus on business information, professional events and communities. Fierce Pharma is an established information and events brand for the pharmaceutical industry, while Fierce Pharma Week brings together senior leaders from across different functions within the sector. With Fierce Pharma Week Europe, the format will come to Europe for the first time, taking place in Basel from 28 to 30 June 2027.
The European edition is aimed at senior professionals from marketing, Medical Affairs, Commercialization and Market Access, PR and communications, as well as related fields. Key topics include the commercialization of new therapies, Market Access, AI, Medical Communications and collaboration across functions and national borders. The result is a platform designed not only to share knowledge, but also to foster targeted exchange across the industry.
Basel was a natural choice. The region is home to more than 800 life sciences companies, over 1,000 research groups and around 33,000 professionals. The combination of industry, research and a dense network of institutions creates an environment where international congresses and professional events connect with an already highly networked ecosystem.
For the Messe und Congress Center Basel, Fierce Pharma Week Europe is also a natural extension of an established portfolio of life sciences events. International formats such as Swiss Biotech Days, Future Labs Live, BioTechX and Festival of Biologics regularly bring professionals and senior decision-makers from across the industry together at our venue. Fierce Pharma Week Europe adds a format that reaches further topics and target groups while expanding exchange within the life sciences community. Our flexible combination of congress, exhibition and networking spaces provides the right setting for this type of event.
For MCH Group, partnerships like this form part of a broader strategic approach: connecting international organisers and communities with the strengths of the destination. This creates new opportunities for knowledge exchange, networking and international visibility – while further strengthening Basel as a destination for relevant events in the life sciences sector.